The IRIS-Resolute Integrity (IRIS-Integrity)
NCT01392846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2021-09-13
Summary
This is a prospective, observational, cohort study to evaluate the relative efficacy and safety of Resolute Integrity stent compared to other (drug eluting stents) DES.
Conditions
Sponsors & Collaborators
-
CardioVascular Research Foundation, Korea
collaborator OTHER - collaborator INDUSTRY
-
Seung-Jung Park
lead OTHER
Principal Investigators
-
Seung-Jung Park, MD, PhD · Asan Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-07-31
- Primary Completion
- 2016-01-20
- Completion
- 2020-03-02
Countries
- South Korea
Study Locations
More Related Trials
-
Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)
NCT01350778 ·Status: COMPLETED
-
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
NCT01186133 ·Status: RECRUITING
-
LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)
NCT01489761 ·Status: TERMINATED ·Phase: PHASE4
-
A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease
NCT03376646 ·Status: COMPLETED ·Phase: NA
-
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
NCT00960908 ·Status: UNKNOWN
-
Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)
NCT05448625 ·Status: COMPLETED
-
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
NCT03507205 ·Status: COMPLETED
-
Evaluation of Effectiveness and Safety of NOBORI Stent
NCT01348360 ·Status: COMPLETED
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
NCT01078038 ·Status: COMPLETED ·Phase: PHASE4
-
Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
NCT02193971 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)
NCT02452736 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)
NCT01515228 ·Status: COMPLETED ·Phase: PHASE4
-
Resolute Integrity US Extended Length Sub-Study(RI US XL)
NCT01913600 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System
NCT01638507 ·Status: COMPLETED ·Phase: NA
-
New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )
NCT01365572 ·Status: UNKNOWN ·Phase: PHASE4
-
DESyne in Routine Clinical Practice
NCT02039713 ·Status: TERMINATED
-
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation
NCT02978456 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
NCT07098195 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of Drug Eluting Balloon and Drug Eluting Stent
NCT01539603 ·Status: COMPLETED ·Phase: PHASE2
-
DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold
NCT03074305 ·Status: WITHDRAWN ·Phase: NA
-
A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions
NCT02796157 ·Status: UNKNOWN ·Phase: NA
-
COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease
NCT01752127 ·Status: UNKNOWN ·Phase: PHASE3
-
CONNECT DES Registrty
NCT04715594 ·Status: UNKNOWN
-
Orsiro™ Drug Eluting Stent in Routine Clinical Practice
NCT02039739 ·Status: COMPLETED
-
Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions
NCT02360423 ·Status: UNKNOWN ·Phase: PHASE3